Cidara Announces Pricing of Upsized Public Offering of Common Stock - Cidara Therapeutics (NASDAQ:CDTX)

Cidara Announces Pricing of Upsized Public Offering of Common Stock - Cidara Therapeutics (NASDAQ:CDTX)

SAN DIEGO, June 24, 2025 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. ("Cidara") (NASDAQ:CDTX), a biotechnology company using its proprietary Cloudbreak® platform to develop drug-Fc conjugate (DFC) therapeutics, today announced the pricing of an underwritten public offering of 7,954,546 shares of its common stock at a price to the public of $44.00 per share. All of the shares are to be sold by Cidara. The gross proceeds to Cidara from the offer…

Cidara Announces Pricing of Upsized Public Offering of Common Stock - Cidara Therapeutics

Open the article to view the coverage from cidara.com

Biotech Cidara Secures Massive $350M Funding Through Upsized Public Offering, Major Banks Lead

Cidara raises $350M through upsized public offering at $44/share, backed by JP Morgan and Morgan Stanley. See complete offering terms and institutional support.